MedPath

Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care

Not Applicable
Completed
Conditions
Diabetes Mellitus
Coronary Artery Disease
Hypertension
Atrial Fibrillation
Stroke
Interventions
Other: PHCVRS Intervention
Other: Personal Health Record
Registration Number
NCT01983813
Lead Sponsor
Korey Kennelty
Brief Summary

The trial will examine whether a centralized Prevention Health \& Cardiovascular Risk Service (PHCVRS) run by clinical pharmacists at the University of Iowa can be implemented in primary care offices and whether it can improve the care delivered to patients at risk for developing cardiovascular disease.

Detailed Description

The use of clinical pharmacists in primary care has improved the control of several chronic cardiovascular conditions. However, many private physician practices lack the resources to implement team-based care with pharmacists. The purpose of this study was to evaluate whether a centralized, remote, clinical pharmacy service could improve guideline adherence and secondary measures of cardiovascular risk in primary care offices in rural and small communities.

This study was a prospective trial in 12 family medicine offices cluster randomized to either the intervention or usual care. The intervention was delivered for 12 months, and subjects had research visits at baseline and 12 months. The primary outcome was adherence to guidelines, and secondary outcomes included changes in key cardiovascular risk factors and preventative health measures. We enrolled 302 subjects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
302
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PHCVRS interventionPHCVRS InterventionEach participant will receive communication with a clinical pharmacist for 12 months to decrease risk of developing cardiovascular disease.
PHCVRS interventionPersonal Health RecordEach participant will receive communication with a clinical pharmacist for 12 months to decrease risk of developing cardiovascular disease.
Usual care/Personal Health RecordPersonal Health RecordWill receive usual medical care plus access to an online Personal Health Record, where the participant can document medications and diagnosed conditions.
Primary Outcome Measures
NameTimeMethod
Adherence of medical regimen/treatment to all of the Guideline Advantage criteria that apply.12 months for each participant

The primary outcome measure was adherence to the GA criteria as a surrogate for quality of care because each subject had varying gaps in guideline-concordant care, depending on their specific cardiovascular conditions and preventative care needs.

Secondary Outcome Measures
NameTimeMethod
Control of blood pressure, low density lipoprotein cholesterol and hemoglobin A1c.12 months for each participant

Secondary aims included control of BP, diabetes mellitus, and lipids for subjects whose conditions were not controlled at baseline.

Trial Locations

Locations (12)

Akron Mercy Medical Clinic

🇺🇸

Akron, Iowa, United States

Iowa Specialty Hospitals - Belmond Clinic

🇺🇸

Belmond, Iowa, United States

Employee Health Clinic, Mercy Cedar Rapids

🇺🇸

Cedar Rapids, Iowa, United States

Iowa Speciality Hospitals - Clarion Clinic

🇺🇸

Clarion, Iowa, United States

Great River Medical Group

🇺🇸

Davenport, Iowa, United States

Grinnell Regional Family Practice

🇺🇸

Grinnell, Iowa, United States

Des Moines University Family Medicine Clinic

🇺🇸

Des Moines, Iowa, United States

Knoxville Hospital Clinic

🇺🇸

Knoxville, Iowa, United States

Newton Clinic, P.C.

🇺🇸

Newton, Iowa, United States

UI Health Care-River Crossing

🇺🇸

Riverside, Iowa, United States

Siouxland Community Health Center

🇺🇸

Sioux City, Iowa, United States

Burlington Area Family Practice Center

🇺🇸

West Burlington, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath